Exact Mass: 557.4291304000001
Exact Mass Matches: 557.4291304000001
Found 86 metabolites which its exact mass value is equals to given mass value 557.4291304000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vecuronium
Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. [PubChem] D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
Vecuronium
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
acetic acid [(2S,3S,5R,8S,9R,10R,13R,14R,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-1-piperidin-1-iumyl)-2-(1-piperidinyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] ester
[3-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
(4E,8E)-3-hydroxy-2-(pentadecanoylamino)hexadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(octadecanoylamino)trideca-4,8-diene-1-sulfonic acid
(4E,8E)-2-(dodecanoylamino)-3-hydroxynonadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]dodec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]hexadec-4-ene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(undecanoylamino)icosa-4,8-diene-1-sulfonic acid
2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxypentadecane-1-sulfonic acid
(4E,8E)-2-(decanoylamino)-3-hydroxyhenicosa-4,8-diene-1-sulfonic acid
(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid
2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxytetradecane-1-sulfonic acid
3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]undecane-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]undec-4-ene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]heptadec-4-ene-1-sulfonic acid
(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxypentadec-4-ene-1-sulfonic acid
(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytetradec-4-ene-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]dodecane-1-sulfonic acid
3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]tridecane-1-sulfonic acid
(4E,8E)-2-(heptadecanoylamino)-3-hydroxytetradeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(tetradecanoylamino)heptadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]octadec-4-ene-1-sulfonic acid
2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxydecane-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(tridecanoylamino)octadeca-4,8-diene-1-sulfonic acid
(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid
(4E,8E)-2-(hexadecanoylamino)-3-hydroxypentadeca-4,8-diene-1-sulfonic acid
(4E,8E)-3-hydroxy-2-(nonadecanoylamino)dodeca-4,8-diene-1-sulfonic acid
4-(3-Butanoyloxy-2-heptadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Dodecanoyloxy-3-nonanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Heptanoyloxy-2-tetradecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Hexanoyloxy-2-pentadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Octadecanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Hexadecanoyloxy-3-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Octanoyloxy-2-tridecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Acetyloxy-2-nonadecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(3-Decanoyloxy-2-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
4-(2-Decanoyloxy-3-undecanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate
N-[(2S,3R,4E,6E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,6-dien-2-yl]decanamide
N-[(2S,3R,4E,8E)-3-hydroxy-1-[(2R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradeca-4,8-dien-2-yl]decanamide
Vecuronium
A 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidino- and 16beta-N-methylpiperidinium substituents. D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents M - Musculo-skeletal system > M03 - Muscle relaxants > M03A - Muscle relaxants, peripherally acting agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists